Intensifying Competition and Pricing Downside Risk in the Research Reagent Market
First written in FY2016. 4 of 6 entries say "Restated". Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025RestatedAnnual report
「The field of reagent services used for research by pharmaceutical companies, universities, and other institutions is highly fluid, and generating stable earnings is difficult in a fiercely competitive global market. The Company is strengthening its digital marketing, building an information strategy using social media and other channels, and seeking to expand sales by promoting its proprietary technologies in Japan and worldwide.」
The Company continues to recognize that stable earnings are difficult to generate in the research reagent market because of its fluidity and intense competition, and identifies stronger digital marketing as a response. - FY2021RestatedAnnual report
「However, the domestic market for research reagents and contract services, which form the foundation of the Company's business, has many competitors relative to its size, limiting future earnings growth. Demand is also subject to instability depending on researchers' areas of focus.」
The Company continues to identify the large number of competitors, limited earnings growth, and demand fluctuations based on research themes as risks in the research reagent and contract services market. - FY2020WorsenedAnnual report
「The domestic market for research reagents and contract services, which form the foundation of the Company's business, has many competitors relative to its size, limiting future earnings growth. Demand is also subject to instability depending on researchers' areas of focus.」
The Company specifically describes the large number of competitors, limited earnings growth, and unstable demand in the research reagent and contract services market. - FY2019RestatedAnnual report
「In addition, sales competition with rival companies has intensified in recent years, accelerating price declines, and a sharp expansion of the market appears unlikely.」
The Company continues to disclose the risks of intensifying competition, falling prices, and sluggish sales and margin growth in the research reagent market. - FY2017RestatedAnnual report
「In addition, sales competition with rival companies has intensified in recent years, accelerating price declines, and a sharp expansion of the market appears unlikely.」
The risks of intensifying competition, falling prices, and sluggish earnings growth in the research reagent market are reiterated. - FY2016First statedAnnual report
「In addition, sales competition with rival companies has intensified in recent years, accelerating price declines, and a sharp expansion of the market appears unlikely.」
The disclosure indicates that intensifying competition and falling prices could cause stagnant sales and lower profit margins.